* Investors focus on Jackson Hole Fed gathering this week
* Crude prices extend drop on fears recent rally overdone
TOKYO, Aug 23 (Reuters) - Japan's Nikkei share average slipped on Tuesday, pressured by a stronger yen and slumping oil prices, though trading was thin as investors awaited a Federal Reserve gathering later this week in Jackson Hole, Wyoming.
"It is a particularly egregious vacuum of data and events ahead of Jackson Hole, with all eyes on that particular event," said Stefan Worrall, director of Japan equity sales at Credit Suisse (SIX: CSGN ) in Tokyo.
Global central bankers will gather for the Fed's annual mountain retreat from Thursday. Fed Chair Janet Yellen is slated to speak on Friday, and could offer clues on the timing of the U.S. central bank's next monetary policy move.
Wall Street ended little changed on Monday, in low volume trade, as investors fretted about the impact of weakening oil prices and the odds of whether the Fed will raise interest rates in the coming months. .N
The Nikkei stock index .N225 was down 0.3 percent at 16,557.41 in late morning trade, dampened by the effects of a stronger currency.
The dollar was down 0.1 percent at 100.22 yen JPY= , not far from levels under 100 yen touched last week. FRX/
"There is a chance that the 100-yen level will be broken again, which would put pressure on the Nikkei," said Yutaka Miura, senior technical analyst at Mizuho Securities in Tokyo.
Weaker oil prices also dented sentiment. Crude oil prices fell as analysts, including Goldman Sachs (NYSE: GS ), warned that a price rally in August had been overdone, and that a proposed oil production freeze at current near record levels would not help rein in an oversupplied market. O/R
Expectations of government stimulus lent some support to the wilting market. Japan's government is preparing a $33 billion supplementary budget to help fund Prime Minister Shinzo Abe's economic stimulus package, largely financed by construction bonds, according to a draft seen on Monday by Reuters. Pharmaceutical Co Ltd 4528.T soared as much as 7.5 percent and was one of the most traded issues by turnover. It gained after business daily Nikkei reported that the company would start selling its Opdivo cancer drug as a blood cancer treatment covered by Japan's health insurance within the year, citing President Gyo Sagara. broader Topix .TOPX was 0.3 percent lower at 1,300.25, and the JPX-Nikkei Index 400 .JPXNK400 was also down 0.3 percent at 11,686.11. (By Tokyo markets team; Editing by Jacqueline Wong)
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.